buthionine sulfoximine has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manna, SK; Ramesh, GT; Sarkar, A; Sreenivasan, Y | 1 |
1 other study(ies) available for buthionine sulfoximine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Buthionine Sulfoximine; Calcium-Binding Proteins; Catalase; Cell Line; Cyclooxygenase 2; Drug Synergism; Enzyme Activation; Gene Expression; Glutamate-Cysteine Ligase; Glutathione; HeLa Cells; Humans; I-kappa B Kinase; Intercellular Adhesion Molecule-1; Isoenzymes; Jurkat Cells; Lymphoma, Large B-Cell, Diffuse; Membrane Glycoproteins; Membrane Proteins; Mice; Nerve Tissue Proteins; NF-kappa B; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Synaptotagmin I; Synaptotagmins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Xanthones | 2004 |